Review of the Chinese Landscape in Phase 1 Clinical Trials for Noncancer Innovative Drugs Over 2015 to 2020
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.1131
Abstract: In recent years, the research and development (R&D) of innovative drugs in China has been dramatically accelerated. And the early clinical study is crucial for drug R&D. However, little is known involving the change of… read more here.
Keywords: clinical trials; innovative drugs; drug; phase clinical ... See more keywords
Pharmacoeconomic Results Of Highly Innovative Drugs Approved For Temporary Reimbursement In The Czech Republic
Sign Up to like & getrecommendations! Published in 2017 at "Value in Health"
DOI: 10.1016/j.jval.2017.08.1666
Abstract: 1 Decree No. 376/2011 Coll., implementing some of provisions of the Act on Public Health Insurance. • 2 State Institute of Drug Control. Evaluation of cost-effetiveness Guidelines. 17/05/2017. • 3 Act No. 48/1997 Coll., onPpublic… read more here.
Keywords: drugs approved; results highly; approved temporary; highly innovative ... See more keywords
The Entry Lag of Innovative Drugs in Russia, 2010–2019
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph18105052
Abstract: Objective: Evaluation of the lag timelines for the launch of innovative drugs to the Russian market and pharmacoeconomic factors they can depend on. Methods: To complete the investigation, we used information about drug products, namely,… read more here.
Keywords: lag innovative; drug; entry lag; innovative drugs ... See more keywords